156 related articles for article (PubMed ID: 22231405)
1. Anaplastic oligodendroglioma with ganglioglioma-like maturation.
Tanaka Y; Nobusawa S; Yagi S; Ikota H; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2012 Oct; 29(4):221-8. PubMed ID: 22231405
[TBL] [Abstract][Full Text] [Related]
2. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity.
Rodriguez FJ; Perry A; Rosenblum MK; Krawitz S; Cohen KJ; Lin D; Mosier S; Lin MT; Eberhart CG; Burger PC
Acta Neuropathol; 2012 Nov; 124(5):627-41. PubMed ID: 22941225
[TBL] [Abstract][Full Text] [Related]
3. Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas.
Okada M; Yano H; Hirose Y; Nakayama N; Ohe N; Shinoda J; Iwama T
Brain Tumor Pathol; 2011 Apr; 28(2):157-61. PubMed ID: 21312066
[TBL] [Abstract][Full Text] [Related]
4. A rare case of oligodendroglioma with gangliocytic differentiation in a 31-year-old male: importance of genetic testing for IDH1/2.
Park JH; Cha YJ; Chang JH; Lee SK; Kim SH
Brain Tumor Pathol; 2020 Jul; 37(3):95-99. PubMed ID: 32504153
[TBL] [Abstract][Full Text] [Related]
5. A case of oligodendroglioma with prominent neuronal differentiation.
Hirose T; Nobusawa S; Nakazato Y; Sasaki A
Hum Pathol; 2013 Oct; 44(10):2353-9. PubMed ID: 24054724
[TBL] [Abstract][Full Text] [Related]
6. Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall.
Perry A; Burton SS; Fuller GN; Robinson CA; Palmer CA; Resch L; Bigio EH; Gujrati M; Rosenblum MK
Acta Neuropathol; 2010 Aug; 120(2):237-52. PubMed ID: 20464403
[TBL] [Abstract][Full Text] [Related]
7. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors.
Hirose T; Ishizawa K; Shimada S
Neuropathology; 2010 Dec; 30(6):586-96. PubMed ID: 20408960
[TBL] [Abstract][Full Text] [Related]
8. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma.
Mut M; Güler-Tezel G; Lopes MB; Bilginer B; Ziyal I; Ozcan OE
Clin Neuropathol; 2005; 24(5):225-9. PubMed ID: 16167546
[TBL] [Abstract][Full Text] [Related]
9. A distinct pattern of Olig2-positive cellular distribution in papillary glioneuronal tumors: a manifestation of the oligodendroglial phenotype?
Tanaka Y; Yokoo H; Komori T; Makita Y; Ishizawa T; Hirose T; Ebato M; Shibahara J; Tsukayama C; Shibuya M; Nakazato Y
Acta Neuropathol; 2005 Jul; 110(1):39-47. PubMed ID: 15906048
[TBL] [Abstract][Full Text] [Related]
10. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
Capper D; Reuss D; Schittenhelm J; Hartmann C; Bremer J; Sahm F; Harter PN; Jeibmann A; von Deimling A
Acta Neuropathol; 2011 Feb; 121(2):241-52. PubMed ID: 21069360
[TBL] [Abstract][Full Text] [Related]
11. Oligodendroglial ganglioglioma.
Yamashita S; Yokogami K; Niibo T; Takeishi G; Ikeda T; Miyata S; Uehara H; Fukushima T; Nakazato Y; Takeshima H
Brain Tumor Pathol; 2011 Oct; 28(4):311-6. PubMed ID: 21725645
[TBL] [Abstract][Full Text] [Related]
12. Pleomorphic xanthoastrocytoma as a component of a temporal lobe cystic ganglioglioma: a case report.
Sugita Y; Irie K; Ohshima K; Hitotsumatsu T; Sato O; Arimura K
Brain Tumor Pathol; 2009; 26(1):31-6. PubMed ID: 19408095
[TBL] [Abstract][Full Text] [Related]
13. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.
Kreiger PA; Okada Y; Simon S; Rorke LB; Louis DN; Golden JA
Acta Neuropathol; 2005 Apr; 109(4):387-92. PubMed ID: 15739101
[TBL] [Abstract][Full Text] [Related]
14. Granular cells in oligodendroglioma suggest a neoplastic change rather than a reactive phenomenon: case report with molecular characterisation.
Rao S; Sravya P; Chandran C; Saini J; Somanna S; Santosh V
Brain Tumor Pathol; 2017 Jan; 34(1):42-47. PubMed ID: 27738816
[TBL] [Abstract][Full Text] [Related]
15. [Glioneuronal tumor with neuropil-like island: report of four cases and review of literature].
Duan ZJ; Yao K; Qi XL
Zhonghua Bing Li Xue Za Zhi; 2016 May; 45(5):324-8. PubMed ID: 27142914
[TBL] [Abstract][Full Text] [Related]
16. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
17. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
[TBL] [Abstract][Full Text] [Related]
18. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections.
Burger PC; Minn AY; Smith JS; Borell TJ; Jedlicka AE; Huntley BK; Goldthwaite PT; Jenkins RB; Feuerstein BG
Mod Pathol; 2001 Sep; 14(9):842-53. PubMed ID: 11557779
[TBL] [Abstract][Full Text] [Related]
19. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
Gupta M; Djalilvand A; Brat DJ
Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
[TBL] [Abstract][Full Text] [Related]
20. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
